AstraZeneca Net Worth 2006-2021 | AZN

Interactive chart of historical net worth (market cap) for AstraZeneca (AZN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AstraZeneca net worth as of October 20, 2021 is $186.42B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $186.421B $26.617B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $431.385B 17.19
Novo Nordisk (NVO) Denmark $246.430B 34.20
Pfizer (PFE) United States $235.986B 13.40
Eli Lilly (LLY) United States $232.381B 30.18
Merck (MRK) United States $201.219B 13.78
AbbVie (ABBV) United States $189.883B 9.10
Novartis AG (NVS) Switzerland $185.985B 13.81
GlaxoSmithKline (GSK) United Kingdom $105.469B 13.23